
Diaceutics Plc (DXRX)
LSE
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 4.59M | 7.37M | 10.37M | 13.44M | 12.7M | 13.94M | 19.5M | 23.7M |
Operating Income | 837k | 1.21M | 1.13M | 740k | -716k | 550k | 575k | -3.02M |
Pre Tax Income | 785k | 785k | 877k | 497k | -682k | 462k | 564k | -2.44M |
Net Income | 747k | 663k | 632k | 398k | 263k | 561k | 724k | -1.75M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 2490 | 2286.2 | 0.9 | 0.6 | 0.3 | 0.7 | 0.9 | -2.1 |
EBIT | 837k | 1.21M | 1.13M | 740k | -716k | 550k | 575k | -3.02M |
EBITDA | 1.01M | 1.24M | 1.25M | 1.02M | 93k | 2.35M | 3.58M | 1.76M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.